Impact of enteral supplements enriched with ω-3 fatty acids and/or ω-6 fatty acids, arginine and ribonucleic acid compounds on leptin levels and nutritional status in active Crohn's disease treated with prednisolone

Digestion

Volumn 75, Issue 1, 2007, Pages 10-16

  Nielsen, Aneta Aleksandra ^a   Nielsen, Jens Nederby ^a   Grønbæk, Henning ^b   Eivindson, Martin ^b   Vind, Ida ^c   Munkholm, Pia ^c   Brandslund, Ivan ^a,d   Hey, Henrik ^a,d  

^a LILLEBAELT HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

3 fatty acids; 6 fatty acids; Body mass index; Crohn's disease; Leptin; Triglycerides

Indexed keywords

ARGININE; CHOLESTEROL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PREDNISOLONE; RNA; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DIET SUPPLEMENTATION; DISEASE MARKER; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; ENTERIC FEEDING; FEMALE; HUMAN; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; ARGININE; BODY MASS INDEX; CROHN DISEASE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; GLUCOCORTICOIDS; HUMANS; LEPTIN; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PREDNISOLONE; RNA;

EID: 34248215277     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101560     Document Type: Article

References (33)

1. Pond CM: Long-term changes in adipose tissue in human disease. Proc Nutr Soc 2001; 60:365-374.
2. Goh J, O'Morain CA: Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther 2003;17:307-320.
3. Beattie RM, Bentsen BS, MacDonald TT: Childhood Crohn's disease and the efficacy of enteral diets. Nutrition 1998;14:345-350.
4. Escher JC, Taminiau JA: Treatment of inflammatory bowel disease in childhood. Scand J Gastroenterol Suppl 2001;234:48-50.
5. Verma S, Kirkwood B, Brown S, Giaffer MH: Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease. Dig Liver Dis 2000;32:769-774.
6. Johnson T, Macdonald S, Hill SM, Thomas A, Murphy MS: Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut 2006;55:356-361.
7. Sakurai T, Matsui T, Yao T, Takagi Y, Hirai F, Aoyagi K, Okada M: Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas. JPEN J Parenter Enteral Nutr 2002;26:98-103.
8. Bjorkkjaer T, Brunborg LA, Arslan G, Lind RA, Brun JG, Valen M, Klementsen B, Berstad A, Froyland L: Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil. Scand J Gastroenterol 2004;39:1088-1094.
9. Lippuner K, Casez JP, Horber FF, Jaeger P: Effects of deflazacort versus prednisone on bone mass, body composition, and lipid profile: a randomized, double blind study in kidney transplant patients. J Clin Endocrinol Metab 1998;83:3795-3802.
10. Steiger U, Lippuner K, Jensen EX, Montandon A, Jaeger P, Horber FF: Body composition and fuel metabolism after kidney grafting. Eur J Clin Invest 1995;25:809-816.
11. Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 1998;395:763-770.
12. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995;1:1155-1161.
13. Hoppin AG, Kaplan LM, Zurakowski D, Leichtner AM, Bousvaros A: Serum leptin in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1998;26:500-505.
14. Kabata T, Kubo T, Matsumoto T, Hirata T, Fujioka M, Takahashi KA, Yagishita S, Kobayashi M, Tomita K: Onset of steroid-induced osteonecrosis in rabbits and its relationship to hyperlipaemia and increased free fatty acids. Rheumatology (Oxford) 2005; 44:1233-1237.
15. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F: Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 1998;97:1029-1036.
16. Best WR, Becktel JM, Singleton JW, Kern F Jr: Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-444.
17. Jorgensen LG, Fredholm L, Hyltoft PP, Hey H, Munkholm P, Brandslund I: How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)? Clin Chem Lab Med 2005;43: 403-411.
18. Munkholm P: Crohn's disease-occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull 1997;44:287-302.
19. Udden J, Bjorntorp P, Arner P, Barkeling B, Meurling L, Rossner S: Effects of glucocorticoids on leptin levels and eating behaviour in women. J Intern Med 2003;253:225-231.
20. Wallace AM, Tucker P, Williams DM, Hughes IA, Ahmed SF: Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia. Clin Endocrinol (Oxf) 2003;58:770-776.
21. Jørgensen LGM, Hey H, Brandslund I, Eivindson M, Vind I, Gronbaek H, Jensen S, Petersen PH: Quality improvement in wellness reports in patients with Crohn's disease. Accred Qual Assur 2006;11:278-283.
22. Stein RB, Hanauer SB: Comparative tolerability of treatments for inflammatory bowel disease. Drug Saf 2000;23:429-448.
23. Barbier M, Cherbut C, Aube AC, Blottiere HM, Galmiche JP: Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats. Gut 1998; 43:783-790.
24. Gippini A, Mato A, Peino R, Lage M, Dieguez C, Casanueva FF: Effect of resistance exercise (body building) training on serum leptin levels in young men. Implications for relationship between body mass index and serum leptin. J Endocrinol Invest 1999;22: 824-828.
25. Chan DC, Watts GF, Mori TA, Barrett PH, Redgrave TG, Beilin LJ: Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity. Am J Clin Nutr 2003;77:300-307.
26. Durrington PN, Bhatnagar D, Mackness MI, Morgan J, Julier K, Khan MA, France M: An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia. Heart 2001;85:544-548.
27. Laidlaw M, Holub BJ: Effects of supplementation with fish oil-derived n-3 fatty acids and gamma-linolenic acid on circulating plasma lipids and fatty acid profiles in women. Am J Clin Nutr 2003;77:37-42.
28. Wohl DA, Tien HC, Busby M, Cunningham C, Macintosh B, Napravnik S, Danan E, Donovan K, Hossenipour M, Simpson RJ Jr: Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia. Clin Infect Dis 2005;41:1498-1504.
29. Vasandani C, Kafrouni AI, Caronna A, Bashmakov Y, Gotthardt M, Horton JD, Spady DK: Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice. J Lipid Res 2002;43:772-784.
30. Nielsen AA, Jorgensen LG, Nielsen JN, Eivindson M, Gronbaek H, Vind I, Hougaard DM, Skogstrand K, Jensen S, Munkholm P, Brandslund I, Hey H: Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids. Aliment Pharmacol Ther 2005;22:1121-1128.
31. Hanauer SB, Sandborn W: Management of Crohn's disease in adults. Am J Gastroenterol 2001;96:635-643.
32. Munkholm P, Langholz E, Davidsen M, Binder V: Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 1994;35:360-362.
33. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M: Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996;334: 1557-1560.